Cara Therapeutics, Inc. (CARA)
CARA moved a median of -0.56% 30 minutes after news, and -0.86% by the close. How CARA actually reacts to news — the realized, point-in-time move the market made, measured across 143 labeled events over the last three years with zero look-ahead.
CARA’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 41% | 99 |
| 30-min | -0.56% | 46% | 99 |
| 60-min | -0.66% | 42% | 99 |
| to close | -0.86% | 41% | 99 |
| Middle 50% of CARA reactions | -3.35% to +0.74% |
|---|---|
| Median reaction (30-min) | -0.56% |
| Measured reactions | 143 |
Half of all Cara Therapeutics, Inc. news events land between -3.35% and +0.74% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How CARA reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst downgrades | 14 | -9.72% | 14% | -10.60% |
| Coverage initiations | 30 | +0.32% | 63% | +1.47% |
| Rating reiterations | 19 | -0.61% | 47% | -0.91% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. 2 further classes were observed with fewer than 10 measured events and are not published. See how CARA ranks against every other measured name →
That’s how CARA usually reacts — get an email when it moves on news →Email me when CARA moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to CARA's baseline. Nothing else.
Recent CARA events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 10-Q Tvardi Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | — | — | |
| Form 8-K Tvardi Therapeutics, For: May 12 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| Form 8-K/A Tvardi Therapeutics, For: Apr 15 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| Form 8-K Tvardi Therapeutics, For: Apr 15 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| Cara Therapeutics Announces 1-for-3 Reverse Stock Split in Connection with the Proposed Merger with Tvardi Therapeutics | Press release | GlobeNewswire | +9.33% | +5.71% | |
| Form 8-K Cara Therapeutics, Inc. For: Apr 11 | SEC filing · Form 8-K | SEC EDGAR | +0.20% | +11.00% | |
| Form 8-K Cara Therapeutics, Inc. For: Apr 01 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +2.00% | |
| Form 8-K Cara Therapeutics, Inc. For: Mar 24 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -1.19% | |
| Form 10-K Cara Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +0.00% | -1.73% | |
| Form EFFECT Cara Therapeutics, Inc. | SEC filing · Form EFFECT | SEC EDGAR | +0.00% | -4.00% | |
| Form S-4/A Cara Therapeutics, Inc. | SEC filing · Form S-4 | SEC EDGAR | -3.53% | -6.98% | |
| Form S-4/A Cara Therapeutics, Inc. | SEC filing · Form S-4 | SEC EDGAR | -3.84% | -9.68% | |
| Form 8-K Cara Therapeutics, Inc. For: Jan 16 | SEC filing · Form 8-K | SEC EDGAR | -1.72% | -0.86% | |
| Form 8-K Cara Therapeutics, Inc. For: Jan 14 | SEC filing · Form 8-K | SEC EDGAR | -1.72% | -0.86% | |
| Form 8-K Cara Therapeutics, Inc. For: Dec 30 | SEC filing · Form 8-K | SEC EDGAR | +1.91% | +46.41% | |
| Cara Therapeutics Announces Effective Date of 1-for-12 Reverse Stock Split | Press release | GlobeNewswire | +0.00% | -16.00% | |
| Form 8-K/A Cara Therapeutics, Inc. For: Dec 17 | SEC filing · Form 8-K | SEC EDGAR | +3.31% | +7.40% | |
| CARA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Cara Therapeutics, Inc. Is Fair to Shareholders | Press release | Business Wire | -7.96% | +4.84% | |
| Cara Therapeutics and Tvardi Therapeutics Announce Entry into Merger Agreement | Press release | GlobeNewswire | -7.96% | +4.84% | |
| Form 8-K Cara Therapeutics, Inc. For: Dec 17 | SEC filing · Form 8-K | SEC EDGAR | -7.96% | +4.84% | |
| Form S-4 Cara Therapeutics, Inc. | SEC filing · Form S-4 | SEC EDGAR | -2.16% | +57.82% | |
| Form 8-K Cara Therapeutics, Inc. For: Nov 19 | SEC filing · Form 8-K | SEC EDGAR | +0.40% | +0.23% | |
| Form 10-Q Cara Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.41% | -2.87% | |
| Form 10-Q Cara Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | -1.81% | |
| Form 8-K Cara Therapeutics, Inc. For: Jul 31 | SEC filing · Form 8-K | SEC EDGAR | -1.22% | +0.41% | |
| Cara Therapeutics Announces Exploration of Strategic Alternatives | Press release | GlobeNewswire | +6.10% | +18.07% | |
| Form 8-K Cara Therapeutics, Inc. For: Jun 14 | SEC filing · Form 8-K | SEC EDGAR | -5.88% | -5.15% | |
| Cara Therapeutics Announces Outcome of Part A of KOURAGE-1 Study Evaluating Oral Difelikefalin in Notalgia Paresthetica | Press release | GlobeNewswire | -11.37% | -10.60% | |
| Form 8-K Cara Therapeutics, Inc. For: Jun 12 | SEC filing · Form 8-K | SEC EDGAR | -11.37% | -10.60% | |
| Form 8-K Cara Therapeutics, Inc. For: Jun 04 | SEC filing · Form 8-K | SEC EDGAR | +3.65% | +7.36% | |
| Cara Therapeutics Reports First Quarter 2024 Financial Results | Press release | GlobeNewswire | -4.14% | -4.98% | |
| Form 10-Q Cara Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | -4.14% | -4.98% | |
| Form 8-K Cara Therapeutics, Inc. For: May 13 | SEC filing · Form 8-K | SEC EDGAR | -4.14% | -4.98% | |
| Cara Therapeutics to Announce First Quarter 2024 Financial Results on May 13, 2024 | Press release | GlobeNewswire | -0.59% | +0.69% | |
| Form ARS Cara Therapeutics, Inc. For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | -1.92% | -1.61% | |
| Form DEF 14A Cara Therapeutics, Inc. For: Jun 04 | SEC filing · Form DEF | SEC EDGAR | -1.92% | -1.61% | |
| Form DEFA14A Cara Therapeutics, Inc. | SEC filing · Form DEFA14A | SEC EDGAR | -1.92% | -1.61% | |
| Form PRE 14A Cara Therapeutics, Inc. For: Jun 04 | SEC filing · Form PRE | SEC EDGAR | +1.96% | -7.19% | |
| Cara Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference | Press release | GlobeNewswire | -1.38% | +1.57% | |
| Form 8-K Cara Therapeutics, Inc. For: Mar 19 | SEC filing · Form 8-K | SEC EDGAR | +5.63% | -4.31% | |
| Cara Therapeutics to Host Notalgia Paresthetica (NP) Virtual KOL Event on Wednesday, March 27, 2024 | Press release | GlobeNewswire | -0.97% | +3.96% | |
| Form S-8 Cara Therapeutics, Inc. | SEC filing · Form S-8 | SEC EDGAR | -0.97% | +3.96% | |
| Cara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results | Press release | GlobeNewswire | -0.92% | +1.93% | |
| Form 8-K Cara Therapeutics, Inc. For: Mar 04 | SEC filing · Form 8-K | SEC EDGAR | -0.92% | +1.93% | |
| Cara Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024 | Press release | GlobeNewswire | +1.55% | -8.23% | |
| Form 8-K Cara Therapeutics, Inc. For: Feb 01 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +1.97% | |
| Cara Therapeutics Prioritizes Late-Stage Notalgia Paresthetica Program and Extends Cash Runway into 2026 | Press release | GlobeNewswire | +0.47% | -2.90% | |
| Form 8-K Cara Therapeutics, Inc. For: Jan 17 | SEC filing · Form 8-K | SEC EDGAR | -3.14% | -1.18% | |
| Cara Therapeutics Announces Outcome from Dose-Finding Part A of KIND 1 Study Evaluating Oral Difelikefalin for Moderate-to-Severe Pruritus in Patients with Atopic Dermatitis | Press release | GlobeNewswire | -18.50% | -46.23% | |
| Form 8-K Cara Therapeutics, Inc. For: Dec 18 | SEC filing · Form 8-K | SEC EDGAR | -18.50% | -46.23% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the CARA section they belong to.
Where else CARA is measured.
CARA earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Patterson Companies, Inc. (PDCO) | 144 | 0.00% | 48% |
| Propanc Biopharma, Inc. (PPCB) | 144 | 0.00% | 41% |
| Nutriband Inc. (NTRB) | 143 | 0.00% | 44% |
| Redhill Biopharma Ltd. - American Depositary Shares (RDHL) | 143 | -0.50% | 39% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Cara Therapeutics, Inc.'s median reaction calculated?
Every labeled CARA news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 143 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 46% of CARA's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does CARA's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.